Patrick Burnett, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 2,853 shares at $28.81 ($84K) on 2025-12-31, disclosed to the SEC on 2026-01-02.
Seasonal sale ($84k) by See Remarks — this insider has traded ARQT in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.81 | 541 | $16K | 18.7% |
| 2 | $29.39 | 1,156 | $34K | 40.7% |
| 3 | $29.39 | 1,156 | $34K | 40.7% |
| Total | $29.28 avg | 2,853 | $84K | 100% |
| Filing → |
| ARQT | SELL | 2026-08-05 | $25K | — | Filing → |
| ARQT | SELL | 2026-05-13 | $5K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $16K | — | Filing → |